Common Side Effects of Keytruda: What You Need to Know
What is Keytruda?
Keytruda, also known as pembrolizumab, is a medication used to treat various types of cancer, including melanoma, lung cancer, and breast cancer. It is a type of immunotherapy that works by boosting the body's natural defenses to fight cancer cells.
Common Side Effects of Keytruda
While Keytruda has shown promising results in treating cancer, it can cause a range of side effects. Here are some of the most common side effects of Keytruda:
Hypothyroidism (Underactive Thyroid)
* What is it? Keytruda can cause the thyroid gland to become underactive, leading to symptoms such as fatigue, weight gain, and dry skin.
* How common is it? According to the FDA, hypothyroidism is a common side effect of Keytruda, occurring in up to 20% of patients.
Fatigue
* What is it? Fatigue is a common side effect of Keytruda, characterized by feeling tired or lacking energy.
* How common is it? Fatigue is reported by up to 40% of patients taking Keytruda.
Diarrhea
* What is it? Diarrhea is a common side effect of Keytruda, characterized by frequent bowel movements or loose stools.
* How common is it? Diarrhea is reported by up to 30% of patients taking Keytruda.
Rash
* What is it? Rash is a common side effect of Keytruda, characterized by redness, itching, or swelling of the skin.
* How common is it? Rash is reported by up to 20% of patients taking Keytruda.
Itching
* What is it? Itching is a common side effect of Keytruda, characterized by an intense desire to scratch the skin.
* How common is it? Itching is reported by up to 15% of patients taking Keytruda.
Nausea and Vomiting
* What is it? Nausea and vomiting are common side effects of Keytruda, characterized by feelings of queasiness and vomiting.
* How common is it? Nausea and vomiting are reported by up to 10% of patients taking Keytruda.
Other Less Common Side Effects
In addition to the common side effects listed above, Keytruda can also cause a range of less common side effects, including:
* Pneumonitis (inflammation of the lungs)
* Colitis (inflammation of the colon)
* Hepatitis (inflammation of the liver)
* Kidney problems
* Blood clotting disorders
Managing Side Effects of Keytruda
While side effects of Keytruda can be uncomfortable, they are often manageable with medication and other treatments. It is essential to discuss any side effects with your doctor and follow their guidance on managing them.
Conclusion
Keytruda is a powerful medication that has shown promising results in treating various types of cancer. While it can cause a range of side effects, many of these side effects are manageable with medication and other treatments. It is essential to discuss any side effects with your doctor and follow their guidance on managing them.
Key Takeaways
* Keytruda is a medication used to treat various types of cancer.
* Common side effects of Keytruda include hypothyroidism, fatigue, diarrhea, rash, itching, and nausea and vomiting.
* Less common side effects of Keytruda include pneumonitis, colitis, hepatitis, kidney problems, and blood clotting disorders.
* Managing side effects of Keytruda is essential to ensure effective treatment and quality of life.
FAQs
1. What is Keytruda used to treat?
Keytruda is used to treat various types of cancer, including melanoma, lung cancer, and breast cancer.
2. What are the common side effects of Keytruda?
Common side effects of Keytruda include hypothyroidism, fatigue, diarrhea, rash, itching, and nausea and vomiting.
3. How common is hypothyroidism caused by Keytruda?
Hypothyroidism is a common side effect of Keytruda, occurring in up to 20% of patients.
4. Can side effects of Keytruda be managed?
Yes, side effects of Keytruda can be managed with medication and other treatments.
5. What should I do if I experience side effects from Keytruda?
If you experience side effects from Keytruda, discuss them with your doctor and follow their guidance on managing them.
Sources
1. FDA. (2020). Pembrolizumab (Keytruda) Prescribing Information.
2. DrugPatentWatch.com. (2020). Pembrolizumab (Keytruda) Patent Expiration.
3. National Cancer Institute. (2020). Pembrolizumab (Keytruda) Fact Sheet.
4. Merck & Co., Inc. (2020). Keytruda (pembrolizumab) Product Information.
5. American Cancer Society. (2020). Pembrolizumab (Keytruda) Side Effects.